PsychoGenics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PsychoGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7586
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PsychoGenics Inc (PsychoGenics) is a preclinical contract research organization that offers treatment for CNS and orphan disorders.The company’s capabilities include electrophysiology, behavioral testing, translational EEG, molecular biology, quantitative histology and microdialysis. Its proprietary platforms SmartCube, NeuroCubeand PhenoCube are used to screen thousands of compounds forCNS activity and also identify drugs to treat neuropsychiatric disorder. The company also offers support research in areas such as huntington’s disease, parkinson’s disease, autism spectrum disorders, psychosis/schizophrenia, alzheimer’s disease and spinal muscular atrophy, among others. PsychoGenics is headquartered in Paramus, New Jersey, the US.

PsychoGenics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Blue Oak Pharma Enters into Agreement with PsychoGenics 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis’ ESP Technology For Drug Discovery 13
Licensing Agreements 14
PsychoGenics Enters into Licensing Agreement with National Institute of Mental Health 14
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 17
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 18
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 19
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 20
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 21
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 22
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 23
PsychoGenics Inc – Key Competitors 24
PsychoGenics Inc – Key Employees 25
PsychoGenics Inc – Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
PsychoGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PsychoGenics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blue Oak Pharma Enters into Agreement with PsychoGenics 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis' ESP Technology For Drug Discovery 13
PsychoGenics Enters into Licensing Agreement with National Institute of Mental Health 14
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 17
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 18
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 19
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 20
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 21
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 22
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 23
PsychoGenics Inc, Key Competitors 24
PsychoGenics Inc, Key Employees 25

List of Figures
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PsychoGenics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Windtree Therapeutics Inc (WINTD):企業の財務・戦略的SWOT分析
    Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ITOCHU Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    ITOCHU Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DTEK Energy BV:企業の戦略的SWOT分析
    DTEK Energy BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • National Railroad Passenger Corporation:企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Almarai Company:企業の戦略・SWOT・財務情報
    Almarai Company - Strategy, SWOT and Corporate Finance Report Summary Almarai Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Canada Post Corporation:企業の戦略・SWOT・財務分析
    Canada Post Corporation - Strategy, SWOT and Corporate Finance Report Summary Canada Post Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Genalyte Inc:製品パイプライン分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析
    Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dana Brevini Spa:企業の戦略・SWOT・財務分析
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NeuroDerm Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid form …
  • The Boeing Company:企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Catalent Inc:企業の戦略・SWOT・財務情報
    Catalent Inc - Strategy, SWOT and Corporate Finance Report Summary Catalent Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Clayton Homes Inc:企業の戦略・SWOT・財務情報
    Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report Summary Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Partners Group Holding AG (PGHN):企業の財務・戦略的SWOT分析
    Summary Partners Group Holding AG (Partners Group) is a private market investment manager. It offers private equity and investment services. The company manages investment programs and customized portfolios for institutional investors such as insurance companies, pension funds, and sovereign wealth …
  • Anglo American Plc:企業のM&A・事業提携・投資動向
    Anglo American Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo American Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆